Mercia appointed Peter Dines as Investment Director
Based in the Midlands and a highly successful entrepreneur and investor, Peter brings 20 years' experience in the healthcare sector, holding directorships across a wide range of life sciences businesses.
Peter has been involved with a number of high profile, successful investments and exits within the sector including Surgi-C where, as Managing Director, sales quadrupled within three years and the business was subsequently sold to Living Bridge (formerly ISIS Equity Partners).
Other key healthcare positions held, both previously and currently, include Bridges Ventures, Cisiv, Diagnostic World, Spring Active and Newtech Ortho.
Mark Payton, CEO of Mercia Technologies PLC, said:
"We are delighted to welcome Peter to Mercia. Peter is highly regarded for his track record in sourcing and rapidly growing value through hands-on management in businesses within the medtech and life sciences sector.
"Peter joins the three other sector-specific investment directors who lead our investment activity across Digital; Electronics and Hardware; and Advanced Materials, Engineering and Specialised Manufacturing.
"His remit across the Life Sciences sector will be specifically on medtech, contract services and diagnostics."
Mercia Technologies PLCMercia creates, funds and develops technology businesses nationally with an emphasis in the Midlands and the North of the UK. It brings technology transfer, company formation, incubation, commercialisation and investment, to technology ventures.
Mercia has a well seeded portfolio and pipeline of investments. The Group has a direct investment in 12 operating companies and access to a portfolio of 38 businesses through its third party funds, managed by its wholly owned subsidiary Mercia Fund Management.
Mercia's shares started trading on AIM on 18 December 2014.
Комментарии